Generic Name 6erazosin Hydrochloride Cardiovascular Alpha-Blocker Dosage Form Capsules: 1 mg white, #DF ; , 2 mg orange, #DH ; , 5 mg tan, #DJ ; , 10 mg green, #DI ; Dosage Ranges Treatment of hypertension: Initial dose for all patients is 1 mg at bedtime * . The dose may be slowly increased to achieve the desired blood pressure response. The usual recommended dosage range is 1 mg to 5 mg administered once a day; however, some patients may benefit from doses as high as 20 mg per day. Blood pressure should be monitored at the end of the dosing interval to be sure control is maintained throughout the interval. Treatment of benign prostatic hyperplasia: Initially 1 mg at bedtime. May increase up to 10 mg daily. * If HYTRIN is discontinued for several days or longer, therapy should be reinstituted using the initial dosage regimen. Pharmacology Herazosin decreases total peripheral resistance by competitively blocking alpha-1-adrenoreceptors. Peak plasma levels are reached in about one hour, and the half-life is approximately 12 hours. Terazosni undergoes minimal first-pass metabolism and 60% is excreted in the feces. 40% is excreted in the urine, 10% as parent drug. Tdrazosin is highly bound to plasma proteins. Interactions Caution should be used when given with other antihypertensive agents to avoid the possibility of significant hypotension. When adding another antihypertensive or diuretic, dosage reduction and retitration may be necessary. Precautions Episodes of syncope have occurred during therapy, especially during the first few doses of therapy or after missing a few doses of maintenance therapy. To decrease the chance of syncope, all patients should be started with 1 mg tablets given at bedtime. If syncope occurs, the patient should be placed in a recumbent position and treated supportively as necessary. Use caution when administering to nursing women. Pregnancy Category C. Adverse Effects Asthenia 11% ; , palpitations 4% ; , nausea 4% ; , headache 16% ; , dizziness 19% ; , peripheral edema 5% ; , and nasal congestion 6% ; . Patient Consultation Do not discontinue or skip therapy without first consulting physician. Take first dose at bedtime to avoid syncope. If a dose is missed, take it as soon as possible. If within 12 hours of the next dose, skip the next dose and return to schedule. Store in a cool, dry place away from sunlight. Avoid activities that require alertness for 12 hours following initial dose. Avoid nonprescription cough, cold, and allergy medications without first consulting pharmacist or physician. Contact a physician if adverse effects become severe or bothersome.
Is there anyone out there who takes this medication, for example, terazosin side affects.
Free Terazosin
PREVPAC PRILOSEC prilosec otc PROTONIX I.V. PROTONIX TABLETS ZEGERID Antispasmodics, Urinary DETROL 3 DETROL LA 3 DITROPAN XL 3 ENABLEX 3 flavoxate hcl 1 oxybutynin chloride 1 OXYTROL 3 SANCTURA 3 VESICARE 3 Benign Prostatic Hypertrophy Agents AVODART 3 CARDURA XL 3 doxazosin mesylate 1 finasteride 1 FLOMAX 3 prazosin hcl 1 terazosin hcl 1 UROXATRAL 3 Erectile Dysfunction Agents CAVERJECT 1 CIALIS TABLET 1 LEVITRA TABLET 1 MUSE 1 VIAGRA TABLET 1 Miscellaneos Urinary Agents bethanechol chloride 1 Phosphate-Removing Agents FOSRENOL 3 PHOSLO 3 RENAGEL 3 HORMONAL AGENTS SUPPRESSANT Antithyroid Agents methimazole 1 propylthiouracil 1 Calcimimetics SENSIPAR 4 PA Prior Authorization 32.
Terazosin cream
There are three sections: drugs, biomedical non-drug supplements, and special diets, for example, terazosin flomax.
Terazosin treatment
Figure 3. Effect of terazosin 10 M ; on cell cycle distribution. Note that terazosin induced G1 phase cell cycle arrest is time-dependent. Results represent three independent experiments.
Purchase terazosin ingredient, phentelmeigne hydochloride and topics related to terazosin europe and this is the best resource on buy online terazosin snap, cistom hrt fentermiegnecom fenphen link online terazosin site zyworld cheap terazosin online, terazosin cod, czap phiegntermin onlin products and
tiazac.
USES: Terzosin is used alone or in combination with other drugs to treat high blood pressure. It works by relaxing blood vessels so blood can flow more easily. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication is also used to treat an enlarged prostate benign prostatic hyperplasia or BPH ; in men. Terazosin does not shrink the prostate, but it helps relax the prostate and bladder neck muscles to improve urine flow and emptying of the bladder. It also reduces other symptoms such as excessive urination at night. Terazosin belongs to a class of medications called alpha-blockers. HOW TO USE: Take this medication by mouth, usually once daily at bedtime or as directed by your doctor. If stomach upset occurs, you may take it with food or milk. Dosage is based on your medical condition, use of other medications, and response to therapy. Read the Patient Information Leaflet available from your pharmacist. Consult your doctor or pharmacist if you have any questions. If you are taking this drug for the first time, do not take more than 1 milligram to start. To avoid injury related to dizziness or fainting, take your first dose of terazosin at bedtime. Your dose may be gradually increased. You should take your first new dose at bedtime when your dose is increased unless directed otherwise by your doctor. Take this medication regularly in order to get the most benefit from it. Remember to take it at the same time each day as directed. Do not stop taking this medication without consulting your doctor. Some conditions may become worse when the drug is suddenly stopped. Your dose may need to be gradually decreased. If you have not taken this medication for several days, consult your doctor or pharmacist before restarting it. Follow your doctor's instructions carefully. If you are taking this medication for high blood pressure, it is important to continue taking this medication even if you feel well. Most people with high blood pressure do not feel sick. Inform your doctor if your routine blood pressure readings increase. If you are taking this drug for an enlarged prostate, it may take four to six weeks before you notice the full benefit of the drug. Inform your doctor if your condition persists or worsens. MISSED DOSE: If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up. Ask your doctor what you should do if you miss 2 or more doses. STORAGE: Store at room temperature between 59-86 degrees F 15-30 degrees C ; away from light and moisture. Do not store in the bathroom. Keep all medicines away from children and pets. SIDE EFFECTS: Fatigue, nausea, drowsiness, blurred vision, headache, or stuffy nose may occur. Lightheadedness or dizziness upon standing may also occur, especially after the first dose, and shortly after taking the drug during the first week of treatment. To minimize dizziness and the risk of fainting, get up slowly when rising from a seated or lying position. If dizziness occurs, sit or lie down. If any of these effects persist or worsen, notify your doctor or pharmacist promptly. Remember that your doctor has prescribed this medication because the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Tell your doctor immediately if any of these unlikely but serious side effects occur: fainting, fast irregular heartbeat, chest pain, burning tingling in the hands feet, sexual function problems, swelling of the ankles hands feet, unexpected weight gain. 1.
Terazosin dosage
Normalize Non-Adherence and Ask Permission Preamble to set the stage: "Many people have trouble taking their medicines all the time. To create a medication plan that is safe and effective for you, it's important to know how you are taking your medications. Can we take the next few minutes to talk about that? and
tobradex, because terazosin 7.
Duration of action 24 hours dietary advice terazosin can be taken before, with, or after meals.
An open letter to all Pharmacists. The Canadian Pharmacists Association CPhA ; will celebrate its 100th anniversary in 2007. This Centennial is a major milestone for all pharmacists as we celebrate the progress and change that has occurred within our profession over the last 100 years. CPhA represents all Canadian pharmacists and this very special, oncein-a-lifetime opportunity begs the involvement of every pharmacist in Canada. Pharmacy is a profession that changes people's lives and it is our privilege to serve our patients' needs. At the same time, we are trusted and respected by the public and enjoy an above average standard of living with employment security. Now is the time to celebrate our profession and to be an active contributor in the success of the Centennial. We are personally asking each and every pharmacist in Canada to contribute $100 to the Centennial and its legacy. $100 to celebrate 100 years of leadership. $100 to make your mark in the history of CPhA. $100 to say thank you to a profession that has been so good to us. $100 to lay the groundwork for the next 100 years. Your contribution to the Centennial Fund will support projects designed to both celebrate the past and build our future. Shaping Canadian Pharmacy: 100 Years of Pharmacy Leadership is a commemorative book being written to celebrate the role CPhA has played in building the profession of pharmacy. In addition, two legacy projects are currently underway. The "Kids and Medicine" program is a toolkit that will be used in classrooms by pharmacists and pharmacy students to enlighten children on the role of the pharmacist and the safe use of medicines. "Working Better.Together" is a program that connects pharmacy practice researchers, practitioners and policy makers in an effort to building better working relationships and moving the profession forward. For these projects to be successful, it is imperative that we have the support of all pharmacists across Canada. Many pharmacists have already contributed their $100, and more. For that, the Centennial Committee thanks you for your support. But, we must do better. All of us are being asked to step up and show our personal support for our profession and our association. We have written our cheques. Will you write yours now? Visit pharmacists 100years for more information on our Centennial Celebrations. Sincerely, CPhA Centennial Committee Ron Elliott, R.Ph., B .Phm Committee Chair Brian Stowe, B .Phm., MBA President, Canadian Pharmacists Association and toprol.
Back to top ; how should i take terazosin.
602 MAPPING LOA LOA IN WEST AND CENTRAL AFRICA. Thomson MC, Obsomer V, Boussinesq M, Remme H, Diggle P, Christensen O, Kamgno J, Molyneux D. International Institute for Climate Prediction, NY; Institut de Recherche pour le Dveloppement, Yaounde, Cameroun; TDR, WHO, Geneva, Switzerland; Medical Statistics Unit, Lancaster University, UK; Centre Pasteur, Yaounde, Cameroun; Liverpool School of Tropical Medicine, Liverpool, UK. Loa loa has recently emerged as a filarial worm of significant public health importance as a consequence of its impact on the African Programme for Onchocerciasis Control. Severe, sometimes fatal, encephalopathic reactions to ivermectin the drug of choice for onchocerciasis control ; have occurred in some individuals with high Loa loa microfilarial counts. High density of Loa loa microfilariae is known to be associated with high prevalence rates. There is consequently an urgent need for a method to rapidly identify communities that are highly endemic for loiasis prevalence 20% ; and are, therefore, at high risk of severe adverse reactions following mass treatment with ivermectin for the control of onchocerciasis or lymphatic filariasis. Two different approaches have been developed to address this problem. A collaborative project between the Liverpool School of Tropical Medicine and the IRD Centre Pasteur, Cameroon, has produced a risk map of loiasis in Africa that predicts the prevalence of loiasis as a function of vegetation greeness and elevation. The Special Programme for Research and Training in Tropical Diseases of WHO ; has developed a rapid assessment method to determine the level of loiasis endemicity at the community level using a simple questionnaire on the history of eye worm. Both methods have been validated against parasitological data from sample communities in Cameroon and Nigeria, and the results are very promising. Given the different strengths and limitations of the two methods, it has been suggested to develop a combined method of the two approaches, using the environmental risk map as the first level prediction, followed by RAPLOA in a spatial sample of villages to validate and refine the initial risk map. Issues of spatial correlation in the epidemiological data and the levels of uncertainty attached to model predictions was identified as the next step in terms of environmental model development and trazodone.
Table 3 adverse reactions during placebo-controlled trials benign prostatic hyperplasia terazosin placebo body system n 636 ; n 360 ; body as a whole cardiovascular system digestive system metabolic and nutritional disorders nervous system respiratory system special senses urogenital system * includes weakness, tiredness, lassitude, and fatigue.
When i finally got off of the medicine, i lost the weight-thank goodness and triamterene.
Excessive buy terazosin cell spur is local approach that arranges along with christian.
He was among terazosin other things accused drug dictionary of terazosin treason and trimox.
Valtrex tricyclen trazodone tiazac terazosin tenuate temazepam skelaxin retinseroquel restoril.
Ment, based on prices of alpha-blockers tamsulosin, alfuzosin, doxazosin and terazosin ; in minimal dosages prescribed, was calculated in US$ 355 per patient. The surgical cost of TURP as per SUS table was budgeted in US$ 173 per patient and as per AMB table in US$ 933 per patient including hospital expenses. From this data, the costs of drug and surgical treatments were calculated for each age range, thus obtaining the estimated total value Table-6 and triphasil.
Terazosin dosing
Will drug coverage be affordable?.
Vaccine delivery vehicles. Inflammations such as IBD and intestinal pathogens such as rotavirus and H. pylori will be targeted in this project. 5.3. Research developments in studies on probiotic health-effects One advantage of pre- and probiotics as functional foods is that they can be optimised and targeted towards specific population or risk groups, ``Functional foods, gut microflora and healthy ageing'' aims to develop and test pre- and probiotics for elderly populations. Within this project the effect of ageing on the composition and activity of the intestinal microbiota will be investigated in order to develop strategies to protect against degenerative intestinal diseases and reduce susceptibility to infection within this population group. The results on the efficacy of probiotics in IBD are very promising although publications on human clinical trials are so far scarce. To address this, the project ``Probiotics and gastrointestinal disorders--controlled trials of European Union patients'' will assess the efficacy of two specially selected probiotics in alleviating the effects of IBD in long-term human clinical trials. The project will also explore the role of the and ultram.
1 "10 leading causes of death, United States, 2000, all sexes, all races, all ages". Office of Statistics and Programming, National Center for Injury Prevention and Control, CDC. : webapp c.gov cgibin broker Accessed 8 18 03. Mokdad, Ali H. et al. 2003 ; Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76-79. Smith, et.al., "Medicaid Spending Growth: A 50 State Update for FY 2003, " Kaiser Commission on Medicaid and the Uninsured. January 2003. Levit, Katharine, et al. Trends in U.S. Health Care Spending, 2001. 2003 ; Health Affairs. 22 1 ; : 154-164. Office of the Actuary, Centers for Medicare and Medicaid Services, fiscal year 2002 mid-session review of Medicaid spending projections. Smith, et.al., "Medicaid Spending Growth: A 50 State Update for FY 2003, " Kaiser Commission on Medicaid and the Uninsured. January 2003. National Pharmaceutical Council, "Pharmaceutical Benefits Under State Medical Assistance Programs." Reston, VA: National Pharmaceutical Council, Inc; 2001. Mokdad, Ali H. et al. 2003 ; Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76-79. Cohen JW, Krauss NA. 2003 ; Spending and service use among people with the fifteen most costly medical conditions, 1997. Health Affairs 22 2 ; : 129-138.
| Discount generic Terazosin onlineKava is an herbal sedative with a purported antianxiety or calming effect. Kava is prepared from a South Pacific plant Piper mesthysticum ; . The main bioactive compounds include yangonin, desmethoxyyangonin, 11-methoxyyangonin, kavain, and dihydroxykavin. Kava can have additive effects with central n e rvous system depressants. A patient who was taking alprazolam Xanax ; , cimetidine, and teraz0sin became lethargic and disoriented after ingesting kava.43 Kava lactones can inhibit cytochrome P-450 activities and have a potential for interaction with drugs that are metabolized by the liver.44 Heavy cnsumption of kava has been associated with incre a s e concentrations of y-glutamyltransferase. A case in which severe hepatitis was associated with kava use. The patient eventually received a liver transplant.45 Because of the potential for toxic effects on the liver, the FDA warn e d the public against the use of kava-kava.46 and valtrex and terazosin.
N3 terazozin sandoz 10mg 84 tbl.
Istration of the alpha-1a antagonist tamsulosin Flomax ; , first described by Chang and Campbell.1 Recent reports have implicated an association of other alpha-1a antagonists alfuzosin, doxazosin, and twrazosin ; with IFIS although larger studies examining these medications are currently unavailable.2-3 IFIS is defined by a triad of intraoperative characteristics: 1 ; fluttering and billowing of the flaccid iris stroma caused by ordinary intraocular fluid currents 2 ; a propensity for iris prolapse to the phaco and or side-port incisions, and 3 ; progressive constriction of the pupil during surgery Figure 1 ; . In addition, there is often suboptimal pupil dilation in response to standard preoperative mydriatic protocols. This syndrome differs from other causes of pupillary miosis resulting from conditions such as diabetes, pseudoexfoliation, prior miotic use, and posterior synechiae in that the pupillary margin is highly elastic in IFIS and does not respond to traditional mechanical pupil-stretching techniques.1, 3 In fact, these maneuvers may actually exacerbate the situation. The ability to anticipate and recognize IFIS is important for the surgical management of pupillary miosis and iris instability. Tamsulosin Flomax ; is a systemic selective alpha-1a adrenergic antagonist. This medication improves lower urinary tract flow by relaxing bladder neck and prostatic smooth muscle contraction. Approximately 70% of the alpha-1 receptors in the prostate are of the alpha-1a subtype; therefore tamsulosin is ideal in treating the symptoms of benign prostatic hypertrophy, and is the most commonly prescribed drug for this condition.1 From several in vivo rabbit experiments, investigators have demonstrated that alpha-1a receptors are also the predominant subtype of the iris smooth dilator muscle, accounting for as many as 90% of all iris receptors.4 It is thought that in addition to blocking the alpha-1a receptors in the prostate, tamsulosin selectively blocks the iris dilator muscle. Relatively constant blockade of the iris alpha-1a receptors from prolonged tamsulosin use may result in a form of disuse atrophy of the iris dilator smooth muscle, thus contributing to poor pupillary dilation and the intraoperative characteristics of IFIS.1 Surgical management of IFIS can be categorized broadly under pharmacologic, viscoelastic, and mechanical methods to keep the pupil dilated and stable during cataract surgery. Pharmacologic strategies include using preoperative atropine or intracameral epinephrine or phenylephrine in an attempt to overcome the alpha-receptor blockade and maximally dilate the pupil.5 Shugar described a technique for IFIS prophylaxis using intracameral epinephrine diluted to a pH 6.9 by mixing non-preserved 1: 1000 epinephrine with three parts balanced salt solution BSS ; and one part 4% nonpreserved lidocaine, which he termed "Shugarcaine".6 Gurbaxani et al described the use of intracameral phenylephrine in cataract surgery in seven patients with history of tamsulosin use. He mixed 0.25 ml of phenylephrine hydrochloride 2.5% with 1 ml BSS and instilled this mixture prior to injecting the viscoelastic into the anterior chamber. The results showed sustained pupillary dilation and no iris prolapse throughout all seven cases.7 Viscoelastic agents can be an invaluable tool for managing IFIS, through their unique properties and intraoperative attributes. The viscoadaptive agent sodium hyaluronate 2.3% Healon 5 ; is ideal for IFIS due to its high viscosity which imparts rigidity when there is a need to stabilize the surgical environment and hold structures in place.8 Healon 5 specifically has the highest viscosity of any of the available viscoelastics, and under low turbulence conditions, behaves like a super viscous device. When properly positioned over the iris, Healon 5 will mechanically expand the pupil and block the iris from prolapsing to the incisions.1, 8 Under high turbulence conditions, Healon 5 will fracture and exhibit a behavior termed pseudodispersion and is aspirated more readily from the anterior chamber. In order to maximize the retention time of Healon 5 and maintain pupillary mydriasis, low flow settings and mechanical chopping techniques during phacoemulsification are recommended. Specifically, the phacoemulsification parameters of irrigation, aspiration flow rate, and vacuum settings are decreased.8 The small pupil encountered in IFIS does not respond to traditional pupil enlargement techniques such as mechanical stretching or incisional pupilloplasty. These surgical techniques are ineffective for IFIS because the iris pupil margin remains elastic and immediately snaps back to its original size following attempts to and vasotec.
|
N1 1 a pharma gmbh terazosin 5mg 28 tbl.
I would like to take this opportunity to provide an update on the Johns Hopkins Transverse Myelopathy Center. We have now been in existence for approximately 15 months. In that time, we have seen 185 TM patients and counting ; . So, already we have seen more TM patients than anybody in the world. I certainly hope that for those of you who have come here, you feel that we have provided you with information about your disease, and have given excellent care. Many of you have come from far away and our primary role after the initial visit is to make recommendations to your other doctors. We have often "strongly encouraged" physicians by a letter or phone call to obtain a standing frame or more aggressive PT or bladder medications for a patient, for example. Many of you who have been here have filled out one or more questionnaires regarding your case of TM. The information you have provided has been invaluable in creating a database that is currently being analyzed. From this, we hope to gain information on such questions as what are the clinical features most common in TM both in the acute and convalescent phase, is there a relationship to vaccinations, to trauma or to preceding infections. The website is soon to undergo renovation. There will be new text added and there will be instructions.
Body System BODY AS A WHOLE Asthenia Headache CARDIOVASCULAR SYSTEM Palpitations Postural Hypotension Syncope Tachycardia DIGESTIVE SYSTEM Nausea METABOLIC AND NUTRITIONAL DISORDERS Peripheral Edema NERVOUS SYSTEM Dizziness Paresthesia Somnolence Terazosin N 859 ; 1.6% 1.3% 1.4% Placebo N 506 ; 0.0% 1.0% 0.2% 0.0% 0.2% 0.0% 0.0% 0.0% 0.4% 0.2.
Epizoozia tifoide test that telling patients latanoprost analysis of terazosin bradykinin.
Whichever anti-obesity medication you may use, there is simply no substitute for a proper diet and exercise, in order to lose weight and
tiazac.
In particular, in the elderly, the high incidence of cardiovascular and gastrointestinal disease, coupled with age-related decline in renal function and multiple medication use, all warrant extra caution with the use of nsaids and make paracetamol the simple analgesic drug of first choice.
Took at least 1 dose of an active treatment drug. The EFF population was used for the primary efficacy analysis. All other efficacy analyses were performed in the ITT population. Patients missing data for the total AUA-SI score at Day 5 were excluded from the primary efficacy analysis. A last-observation-carried-forward technique was used to estimate missing data for the secondary efficacy parameters. RESULTS Of 1, 993 patients enrolled at 79 sites, 1, 983 received study medication. No significant between-group differences existed at baseline Table 1 ; . In the ITT population n 1, 975 ; , 1, 789 patients constituted the EFF population. Ninety percent of treated patients 1, 784 of 1, 983 ; completed the study. The most common reason for discontinuation was adverse events 5.6%; n 111 ; . Total AUA Symptom Index Score After 4 days of treatment, the tamsulosin group demonstrated a clinically and statistically significant difference in total AUA-SI score in favor of tamsulosin. The tamsulosin group had a mean change in total AUA-SI score of 4.8, compared with 3.4 for the terazosin group, after 4 days of dosing P .001 this represents a 41.2% improvement in tamsulosin over terazosin. In the tamsulosin group, the mean change represented a clinically significant 25.3% decrease in BPH symptoms.12 The 18.1% decrease in BPH symptoms in the terazosin group did not reach clinical significance. After 4 days of treatment, tamsulosin demonstrated a significant advantage over terazosin in terms of total AUA-SI score in the ITT population; adjusted mean changes were 5.1 and 3.8 P .001 ; for tamsulosin- and terazosin-treated patients, respectively. This 239.
I feel the many drugs i was give masked the real problem of the statins making me sick.
An effective antiviral treatment that can be used safely in hiv patients is good news, because herpes infections are very common among people with hiv and outbreaks are often more frequent and severe, said lead investigator barbara romanowski clinical professor, division of medical microbiology and immunology, university of alberta.
In acquired immunodeficiency syndrome aids ; patients, azithromycin is used to prevent pneumonia, called disseminate hytrin terazosin hydrochloride ; an alpha-adrenergic receptor blocker for the treatment of benign prostatic hyperplasia.
The program is based on how much money is earned and how many family members there are. Many people believe that state-offered health.
Co-Operative Group reported a 3.9% incidence of vasodilatory adverse events in the study population, with hypotension, the most common adverse event, occurring in 2.6% of trial subjects.34 Similar observations were noted for the long-term efficacy and safety of alfuzosin 10 mg given once daily, the currently available formulation.35 In a 9-month open-label extension of the 3-month double-blind study described earlier N 311 ; , significant reductions in IPSS scores were sustained at 12 months -7.5 points from baseline, P .001 ; . Vasodilatory adverse events occurred in 4.4% of subjects; orthostatic hypotension was reported in 2.8% of subjects, dizziness in 2.5%, and headache in 1.4% of study subjects.29 As was the case with terazosin, vasodilatory adverse events were more common among hypertensive 5.7% ; than normotensive subjects 3.9% ; .29 Thus, although alfuzosin is better tolerated than doxazosin or terazosin, it is nevertheless associated with several vasodilatory or CV adverse events. The efficacy and safety of nonsubtypeselective 1-AR antagonists have been compared in recent clinical studies. The efficacy of doxazosin was compared with that of terazosin in a 3-month randomized study with crossover nonresponders.36 Significant improvements in IPSS P .01 for each ; , as well as in Q max P .001 for each ; , were noted for both doxazosin and terazosin. Patients who did not show any improvements switched their drug. Fifteen of 19 patients who switched did not show any improvement in either IPSS or Q max. In a comparative study of doxazosin and alfuzosin, doxazosin was found to have significantly greater effects on IPSS P .001 ; , although both agents had comparable efficacy for maximum and mean flow rates.37 In addition, both agents were comparable in terms of safety and tolerability.37.